Circhem Ab Stock Current Liabilities
| CIRCHE Stock | SEK 2.91 0.05 1.75% |
CirChem AB fundamentals help investors to digest information that contributes to CirChem AB's financial success or failures. It also enables traders to predict the movement of CirChem Stock. The fundamental analysis module provides a way to measure CirChem AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CirChem AB stock.
CirChem |
CirChem AB Company Current Liabilities Analysis
CirChem AB's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, CirChem AB has a Current Liabilities of 0.0. This is 100.0% lower than that of the Industrials sector and 100.0% lower than that of the Pollution & Treatment Controls industry. The current liabilities for all Sweden stocks is 100.0% higher than that of the company.
Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
CirChem Fundamentals
| Return On Equity | -0.88 | |||
| Return On Asset | -0.24 | |||
| Operating Margin | (4.97) % | |||
| Current Valuation | 56.2 M | |||
| Shares Outstanding | 17.19 M | |||
| Shares Owned By Insiders | 18.66 % | |||
| Shares Owned By Institutions | 13.24 % | |||
| Price To Book | 1.08 X | |||
| Price To Sales | 20.74 X | |||
| Revenue | 85.55 K | |||
| Gross Profit | (4.79 M) | |||
| EBITDA | (16.74 M) | |||
| Net Income | (18.15 M) | |||
| Cash And Equivalents | 10.05 M | |||
| Cash Per Share | 0.79 X | |||
| Total Debt | 5.59 M | |||
| Debt To Equity | 0.15 % | |||
| Current Ratio | 1.88 X | |||
| Book Value Per Share | 1.46 X | |||
| Cash Flow From Operations | (2.78 M) | |||
| Earnings Per Share | (1.41) X | |||
| Beta | 4.5 | |||
| Market Capitalization | 54.67 M | |||
| Total Asset | 52.14 M | |||
| Z Score | 5.4 | |||
| Net Asset | 52.14 M |
About CirChem AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CirChem AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CirChem AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CirChem AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in CirChem Stock
CirChem AB financial ratios help investors to determine whether CirChem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CirChem with respect to the benefits of owning CirChem AB security.